BONE BIOLOGICS
Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development.
BONE BIOLOGICS
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.bonebiologics.com
Total Employee:
1+
Status:
Active
Contact:
781-552-4452
Email Addresses:
[email protected]
Total Funding:
23.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Stock Details
Investors List
Orthofix, Inc
Orthofix, Inc investment in Post-IPO Equity - Bone Biologics
Hankey Capital
Hankey Capital investment in Post-IPO Equity - Bone Biologics
Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation investment in Post-IPO Equity - Bone Biologics
Hankey Capital
Hankey Capital investment in Seed Round - Bone Biologics
Official Site Inspections
http://www.bonebiologics.com
- Host name: www.itslimo.com
- IP address: 209.76.245.51
- Location: Los Angeles United States
- Latitude: 34.0732
- Longitude: -118.3294
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90010
More informations about "Bone Biologics"
About Us – Bone Biologics
Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor …See details»
Investors – Bone Biologics
Bone Biologics - Crunchbase Company Profile & Funding
Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor …See details»
Bone Biologics Company Profile | Management and Employees …
Bone Biologics Profile and History. Bone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking groundbreaking work with select strategic partners, …See details»
Bone Biologics - LinkedIn
Bone Biologics was founded in 2004 by University of California professors in collaboration with an Osaka University professor and a USC surgeon and acquired in 2006 by MTF as the major shareholder, who has been the primary …See details»
Bone Biologics Corporation (BBLG) - Stock Analysis
Dec 2, 2024 Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s NELL …See details»
Bone Biologics - VentureRadar
Nell-1 is an osteoinductive orthobiologic, a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone …See details»
Bone Biologics - Overview, News & Similar companies - ZoomInfo
Mar 3, 2024 Who is Bone Biologics. Bone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking groundbreaking work with select strategic …See details»
Bone Biologics Company Profile 2024: Stock Performance
Bone Biologics General Information Description. Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in …See details»
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial …
BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has engaged …See details»
Bone Biologics - Craft
Oct 29, 2024 Bone Biologics is a medical device company focused on bone regeneration in spinal fusion. It develops a bone graft substitute product,NELL-1/DBX, an osteostimulative …See details»
Bone Biologics - Company Profile - Tracxn
Nov 5, 2024 Email ID: *****@bonebiologics.com; Key Metrics. Total Funding. $7M in 9 rounds. Latest Funding Round. Post IPO, Nov 16, 2023, $729K. Investors. Hankey Capital & 4 more. …See details»
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
Oct 21, 2024 For more information, please visit www.bonebiologics.com. Forward-Looking Statements. Certain statements contained in this press release, including, without limitation, …See details»
Bone Biologics Reports Progress With NB1 Clinical Program
BURLINGTON, Mass., March 01, 2024--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing …See details»
Newsroom – Bone Biologics
Oct 21, 2024 MTF Biologics is a global nonprofit organization that provides one of the orthopedic industry’s largest portfolios of allograft tissue.See details»
Bone Biologics Corporation (BBLG) - Stock Analysis
Dec 6, 2024 Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization. BURLINGTON, Mass.--(BUSINESS WIRE)--Bone …See details»
Bone Biologics Reports Progress With NB1 Clinical Program
Mar 1, 2024 Bone Biologics Corporation, a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate NB1 into human clinical testing …See details»
Bone Biologics Enters into Supply Agreement with MTF Biologics …
MTF Biologics is a global nonprofit organization that provides one of the orthopedic industry’s largest portfolios of allograft tissue. Bone Biologics (OTC: BBLG) was founded to pursue …See details»
Products – Bone Biologics
NELL-1 Product Pipeline. While Bone Biologics has chosen to focus its initial product development efforts in spinal fusion, we believe that this regenerative medicine technology has …See details»